Clinical Trials Browser

Phase 2 × Bronchiolitis Obliterans Syndrome × nilotinib × Clear all

NCT01844765 2021-04-22

DIALOG

Bronchiolitis Obliterans Syndrome, Bone Marrow Diseases, Hematologic Diseases, Leukemia, Myeloproliferative Disorders, Neoplastic Processes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive